These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 37586865)
1. Effect of monitoring adherence to regular inhaled corticosteroid (ICS) alone or in combination with a long-acting β2-agonist (LABA) using electronic methods on asthma outcomes: a narrative systematic review. Almutairi M; Marriott JF; Mansur A BMJ Open; 2023 Aug; 13(8):e074127. PubMed ID: 37586865 [TBL] [Abstract][Full Text] [Related]
2. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272 [TBL] [Abstract][Full Text] [Related]
3. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
4. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [TBL] [Abstract][Full Text] [Related]
5. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
7. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review. Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TSC BMJ Evid Based Med; 2022 Jun; 27(3):178-184. PubMed ID: 34282031 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ram FS; Cates CJ; Ducharme FM Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901 [TBL] [Abstract][Full Text] [Related]
10. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136 [TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161 [TBL] [Abstract][Full Text] [Related]
12. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cates CJ; Karner C Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340 [TBL] [Abstract][Full Text] [Related]
13. Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids. Kew KM; Beggs S; Ahmad S Cochrane Database Syst Rev; 2015 May; 2015(5):CD011316. PubMed ID: 25997166 [TBL] [Abstract][Full Text] [Related]
14. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Anderson DE; Kew KM; Boyter AC Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488 [TBL] [Abstract][Full Text] [Related]
15. Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Janjua S; Schmidt S; Ferrer M; Cates CJ Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802 [TBL] [Abstract][Full Text] [Related]
16. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195 [TBL] [Abstract][Full Text] [Related]